 Hologic, Inc. NASDAQ:HOLX has announced preliminary first-quarter revenue that beat recent guidance, sending its shares higher. The innovative medical technology company told investors it expects to report total revenues of approximately 1.1 billion for the three months ended December 31, 2022, a decrease of 27 compared to the prior year period - or 25 in constant currency. 